Novartis AG

SWX: CH:NOVN

GO

/zigman2/quotes/203286410/delayed

CHF

80.27

Change

+0.67 +0.84%

Volume

Volume 6.43m

Nov 24, 2020, 5:31 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203286410/delayed

Previous close

CHF 79.60

CHF 80.27

Change

+0.67 +0.84%

Day low

Day high

CHF79.80

CHF80.98

Open
Open: 80.58

52 week low

52 week high

CHF65.09

CHF96.38

Open

Market cap

CHF175.49B

Average volume

5.87M

P/E ratio

27.13

Rev. per Employee

CHF454,248

EPS

2.96

Dividend

2.95

Div yield

3.68%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/ch/novn

MarketWatch News on NOVN

  1. How gene therapy and CRISPR are helping to cure blindness

    7:21 a.m. June 26, 2020

    - Hemant Khanna

  2. Novartis to run COVID-19 trial of antimalaria drug touted by Trump

    8:01 a.m. April 20, 2020

    - Steve Goldstein

  3. European stocks extend rally as recovery hopes continue

    4:57 a.m. April 20, 2020

    - Steve Goldstein

  4. European stocks climb on hopes over coronavirus drug treatment

    10:16 a.m. April 17, 2020

    - Barbara Kollmeyer

  5. 2 ways to trade the VIX right now

    11:26 a.m. Dec. 5, 2019

    - Lawrence G. McMillan

  6. Loading more headlines...
/news/nonmarketwatch/company/ch/novn

Other News on NOVN

  1. Digital Pills That Talk to Your Doctor Are Here

    1:00 p.m. Nov. 14, 2017

    - The Wall Street Journal Interactive Edition

  2. Trump’s Regulators Aim to Boost Growth by Fostering Innovation

    7:23 p.m. Oct. 25, 2017

    - The Wall Street Journal Interactive Edition

  3. Business Watch: News Digest

    9:25 p.m. May 7, 2015

    - The Wall Street Journal Interactive Edition

  4. GSK’s Sturdy Strategy Leaves Investors Waiting

    12:33 p.m. May 6, 2015

    - The Wall Street Journal Interactive Edition

  5. GSK Cuts Return to Shareholders From Novartis Deal

    11:33 a.m. May 6, 2015

    - The Wall Street Journal Interactive Edition

  6. Novartis Sees Benefits of Overhaul

    4:52 a.m. April 23, 2015

    - The Wall Street Journal Interactive Edition

  7. Bristol-Myers Invests in uniQure in Heart-Disease Pact

    10:04 p.m. April 6, 2015

    - The Wall Street Journal Interactive Edition

  8. Bayer CEO Injects a Dose of U.S. Risk-Taking

    1:15 p.m. April 7, 2015

    - The Wall Street Journal Interactive Edition

  9. Swiss Companies Battle Strong Franc

    10:52 a.m. March 2, 2015

    - The Wall Street Journal Interactive Edition

  10. Novartis Japan Ordered to Shut Down 15 Days

    11:59 a.m. Feb. 27, 2015

    - The Wall Street Journal Interactive Edition

  11. Novartis Amends Heart-Drug Trial

    7:32 p.m. Feb. 27, 2015

    - The Wall Street Journal Interactive Edition

  12. New Cancer Technology Cheers Investors

    3:35 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  13. Ten Billion Dollar Ideas You’ve Never Heard Of

    2:24 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  14. CSL Shaves Guidance as Competition Heats Up

    1:11 a.m. Feb. 11, 2015

    - The Wall Street Journal Interactive Edition

  15. Cheap Swiss-Franc Bond Entices Apple

    2:34 p.m. Feb. 10, 2015

    - The Wall Street Journal Interactive Edition

  16. Drug Making Breaks Away From Old Ways

    1:32 a.m. March 9, 2015

    - The Wall Street Journal Interactive Edition

  17. Pfizer to Buy Hospira for $16 Billion

    10:22 a.m. Feb. 6, 2015

    - The Wall Street Journal Interactive Edition

  18. Glaxo Is Still in the Recovery Room

    12:58 p.m. Feb. 4, 2015

    - The Wall Street Journal Interactive Edition

  19. Investors Shouldn’t Fight QE Drag on Corporate Bonds

    2:31 a.m. March 5, 2015

    - The Wall Street Journal Interactive Edition

  20. Glaxo Posts Sharp Fall in Profit

    12:28 p.m. Feb. 4, 2015

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...
/news/pressrelease/company/ch/novn

Press Releases on NOVN

No News currently available for NOVN

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.